InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Ruffolo, John. Officer active across 1 company, notably NervGen Pharma Corp.. In total, 5 filings have been published. Split: 3 buys · 0 sell. Total volume traded: €12k. Activity tracked since 27 May 2026. The latest transaction was disclosed on 4 September 2026 (50 - Grant of options). Regulator: SEDI. The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条